about
Activation of tonsil dendritic cells with immuno-adjuvants.Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapyPresence and phenotype of dendritic cells in uveal melanoma.Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)Petri Net computational modelling of Langerhans cell Interferon Regulatory Factor Network predicts their role in T cell activationPilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.Human Lung Fibroblasts Present Bacterial Antigens to Autologous Lung Th Cells.Mechanisms of local immunosuppression in cutaneous melanoma.Distinct molecular signature of human skin Langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation.The biology of micrometastases from uveal melanoma.Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis.CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.Isolation of inflammatory cells from human tumours.In vitrodiagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactionsMalaria systems immunology: Plasmodium vivax induces tolerance during primary infection through dysregulation of neutrophils and dendritic cellsPresence and maturity of dendritic cells in melanoma lymph node metastasesGenomic programming of IRF4-expressing human Langerhans cells
P50
Q33325670-C78D7D83-2000-4278-82E7-C2B35705F783Q34122814-B6050BAF-60A9-4FBE-A602-4F3E25E7F8E0Q35956391-BE919E94-F70E-448B-8D1B-1CDF2727DFB0Q37336111-E7D23D6A-CAE2-42D7-8F47-79F4F231189CQ38848941-E4A706AB-2F95-40E0-ACBE-233C5B4A611EQ40373444-D5A05A8D-FBCE-4E96-9990-E57E7EA6AD27Q40432385-C15D6064-9FFC-4A1B-9F7C-0404C06A247FQ41808459-40EC85E9-3E79-4BD2-83A1-C768640EF808Q44862540-60CED516-6CB2-4C5E-88A2-A44A8FCB25AEQ45761575-ED58460E-B052-4512-8936-069B25B09307Q50907995-E608F1EE-8B00-47AC-A4CE-A4A5A1BACA4FQ50964324-F0A0A9C3-2019-4ADF-8997-C1D02E9DC466Q53252172-D458D775-1DB8-484D-A716-B531B81F7B62Q58039375-847A9E7D-CE93-40FF-9694-75C9AC7235D6Q58702195-B896FE8D-CD7E-471B-A2DF-9D243912E889Q81898849-CEEAA6A9-4AB9-4C65-9AED-631CFB91ED10Q92711520-E3468E47-7CB7-4F91-881A-AD665D58D451
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marta E Polak
@ast
Marta E Polak
@en
Marta E Polak
@es
Marta E Polak
@nl
Marta E Polak
@sl
type
label
Marta E Polak
@ast
Marta E Polak
@en
Marta E Polak
@es
Marta E Polak
@nl
Marta E Polak
@sl
prefLabel
Marta E Polak
@ast
Marta E Polak
@en
Marta E Polak
@es
Marta E Polak
@nl
Marta E Polak
@sl
P106
P21
P31
P496
0000-0003-2878-476X